• ABOUT ELITE
    • Overview
    • Our Facility
    • Management & Key Employees
    • Our Board
    • Careers
  • PRODUCTS
  • PIPELINE
    • Generic
    • Branded
  • TECHNOLOGY
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • INVESTOR RELATIONS
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
logo image
HOME | CAREERS | CONTACT | NEWS |
Share
Skip to content
  • About Elite
    • Overview
    • Management & Key Employees
    • Our Board
    • Careers
  • Products
  • Pipeline
    • Generic
    • Branded
  • Technology
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • Investor Relations
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
    • Investor Relations
    • Press Releases
    • Events &
      Presentations
    • SEC Filings
    • Shareholder
      Meeting
    • Governance
      Documents
    • Investor Contacts
    • Email Alerts

Press Releases
 
Select:
Jul 16, 2016
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss SequestOx™ Complete Response Letter on Monday, July 18, 2016 at 8:30 AM EDT
Jul 15, 2016
FDA Issues Complete Response Letter for SequestOx™ New Drug Application
Jun 15, 2016
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2016 and Provides Conference Call Information
May 09, 2016
Elite Pharmaceuticals to Present SequestOx™ Data at the American Pain Society 35th Annual Scientific Meeting
May 04, 2016
Elite Pharmaceuticals Appoints Davis S. Caskey to Its Board of Directors
Apr 12, 2016
Elite Pharmaceuticals Announces Changes to their Board of Directors
Mar 17, 2016
Elite Announces U.S. FDA Priority Review Designation for SequestOx™ NDA
Feb 09, 2016
Elite Pharmaceuticals, Inc. Reports Strong Growth for Third Quarter of Fiscal Year 2016
Feb 05, 2016
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2016 Financial Results on February 10, 2016
Jan 13, 2016
FDA Approves Waiver of NDA Filing Fee for Elite Pharmaceuticals
 8   9   10   11   12     13    14   15   16   17   18 
 <<   <   >   >> 
  • Site Map   |  Privacy  |  Terms Of Use
Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.
ART™: Abuse-Resistant Technology for a safer healthier you.
Back to top

Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window